Our Solutions   by Divisions   Generics(Alpha) Division   MinoStrong-F   Leuxa 11.25 mg/vail Injection

Leuxa 11.25 mg/vail Injection

Leuxa 11.25 mg/vail Injection

*To be consumed as directed by physician.

Therapies:

Breast Cancer

Composition:

Leuprolide acetate for injection 11.25 mg/vail

About Leuxa 11.25 mg/vail Injection

Leuxa 11.25 mg/Vial Injection contains Leuprolide Acetate 11.25 mg, a hormone-regulating medicine used to treat advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty (early-onset puberty). It works by reducing the production of certain sex hormones in the body, helping control hormone-dependent conditions and relieving associated symptoms.

Leuxa 11.25 mg/vail Injection

*To be consumed as directed by physician.


Usage Instructions

  • Leuxa 11.25 mg/Vial Injection should be administered only by a qualified healthcare professional at regular intervals as prescribed by your doctor.
  • The treatment schedule may vary depending on the condition being treated.
  • It is important to attend all scheduled appointments to maintain consistent hormone control and achieve optimal treatment outcomes.

    • Benefits and Use

  • Leuxa 11.25 mg/Vial Injection is used in the treatment of advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty.
  • It works by acting on the pituitary gland to reduce the production of testosterone in men and estrogen in women.
  • This helps slow the growth of hormone-dependent tissues, reduces symptoms such as pelvic pain and heavy menstrual bleeding, and helps manage early puberty in children.

    • Safety Information

  • Alcohol: Avoid alcohol consumption during treatment, as it may increase dizziness and may contribute to bone loss.
  • Pregnancy: Leuxa 11.25 mg/Vial Injection is contraindicated during pregnancy and may cause serious harm to the unborn baby. Effective non-hormonal contraception should be used during treatment.
  • Breastfeeding: This medicine should not be used while breastfeeding, as it may pass into breast milk and harm the nursing infant.
  • Driving: This medicine may cause dizziness or affect alertness. Avoid driving or operating machinery if you experience these symptoms.
  • Kidney Disease: Use with caution in patients with kidney disease. Inform your doctor about any kidney-related conditions before starting treatment.
  • Liver Disease: Patients with liver disease should consult their doctor before receiving this medicine. Monitoring may be required during treatment.
  • Heart Conditions: Use with caution in patients with heart disease or those taking medications that affect heart rhythm. Inform your doctor about any cardiac history before treatment.
  • Bone Health: Long-term use may reduce bone mineral density. Adequate calcium intake, vitamin D supplementation, and weight-bearing exercise may be recommended.

    • Ingredients

    Leuprolide Acetate 11.25 mg/Vial

    How to Use

  • Leuxa 11.25 mg/Vial Injection is administered as an injection by a doctor or trained healthcare professional.
  • Do not self-administer this medicine.
  • Follow your doctor's instructions regarding treatment duration, monitoring, and follow-up visits.

    • Storage Information

    Store in a cool, dry place away from direct sunlight and moisture.